查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392088

威爾姆氏腫瘤（腎母細胞瘤）蛋白市場：依產品種類、依應用、依最終使用者、依檢測方法、依階段、按地區

Wilms Tumor Protein Market, By Product Type, By Application, By End User, By Detection Method (Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Western Blotting, Polymerase Chain Reaction, and Others), By Disease Stage, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球威爾姆氏腫瘤（腎母細胞瘤）蛋白市場預計將顯著成長，到 2023 年美國將達到 29.2 億美元。預計到 2030 年將繼續擴大並達到 40 億美元，預測期內年複合成長率(CAGR)為 4.6%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 29.2億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 4.60% 2030年市場規模預測 40億美元
圖 1.威爾姆氏腫瘤蛋白全球市場佔有率(%)（按地區），2023 年
腎母細胞瘤蛋白市場-IMG1

威爾姆氏腫瘤蛋白是一種轉錄因子，在多種癌症的進展中發揮重要作用。它也被證明與化療抗藥性有關。因此， 威爾姆氏腫瘤蛋白被提議作為開發新型抗癌藥物的有希望的標靶。根據 NCBI， 威爾姆氏腫瘤蛋白參與染色質重塑複合物並促進多個基因的表達。它已被證明與多種化療藥物相互作用，包括柔紅黴素和米托蒽醌。

市場動態：

全球癌症患者數量的增加預計將在預測期內推動全球威爾姆氏腫瘤蛋白市場的成長。此外，人們對威爾姆氏腫瘤及其治療和診斷的認知的提高預計也將推動預測期內全球威爾姆氏腫瘤蛋白市場的成長。根據美國癌症協會2020年1月發布的資料，威爾姆氏腫瘤是兒童腎癌的主要形式。美國每年報告 500 至 600 例新威爾姆氏腫瘤病例，這一數字隨著時間的推移保持相對穩定。威爾姆氏腫瘤約佔所有兒童癌症的 5%。

然而，診斷和治療程序的高成本預計將阻礙預測期內全球威爾姆氏腫瘤蛋白市場的成長。診斷和治療程序的高成本可能會嚴重阻礙全球威爾姆氏腫瘤蛋白市場的成長。昂貴的診斷測試和治療方法可能會限制患者的就診，特別是在醫療保健資源有限的地區。這種成本障礙可能會減少患者對威爾姆氏腫瘤蛋白相關治療方法和診斷的採用，這可能會影響市場擴張以及覆蓋更廣泛患者群體的能力。

本研究的主要特點

  • 該報告對全球威爾姆氏腫瘤蛋白市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
  • 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球威爾姆氏腫瘤蛋白市場的主要企業。
  • 該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
  • 威爾姆氏腫瘤蛋白全球市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球威爾姆氏腫瘤蛋白市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
  • 威爾姆氏腫瘤治療對標靶治療的需求不斷增加
  • 癌症診斷和治療領域的技術發展
    • 抑制因素
  • 診斷和治療費用昂貴
    • 機會
  • 威爾姆氏腫瘤研究經費增加
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章 全球威爾姆氏腫瘤蛋白市場－冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球威爾姆氏腫瘤蛋白市場，依產品類型，2018-2030

  • 抗體
  • 檢測套件
  • 重組蛋白
  • 其他

第6章 全球威爾姆氏腫瘤蛋白市場，依應用分類，2018-2030

  • 癌症診斷
  • 癌症治療
  • 研究與開發
  • 其他

第7章 全球威爾姆氏腫瘤蛋白市場，依最終用戶分類，2018-2030 年

  • 醫院
  • 診斷實驗室
  • 研究機構
  • 其他

第8章 全球威爾姆氏腫瘤蛋白市場，依檢測方法，2018-2030

  • 免疫組織化學 (IHC)
  • 酵素免疫分析法測定法 (ELISA)
  • 西方印漬術
  • 聚合酶鍊式反應 (PCR)
  • 其他

第9章 2018-2030 年全球威爾姆氏腫瘤蛋白市場（按階段）

  • 診斷
  • 監測/預測

第10章 全球威爾姆氏腫瘤蛋白市場，依地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第11章競爭形勢

  • Abcam plc.
  • Thermo Fisher Scientific, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Novus Biologicals, LLC
  • R&D Systems, Inc.（a subsidiary of Bio-Techne Corporation）
  • OriGene Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KGaA
  • BioLegend, Inc.
  • Genetex, Inc.（a subsidiary of Novus Biologicals, LLC）
  • Agilent Technologies, Inc.
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Boster Biological Technology
  • Fitzgerald Industries International

第12章章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5825

Global Wilms Tumor Protein Market experienced substantial growth, and is expected to be valued at US$ 2.92 billion in 2023. It is projected to continue expanding, reaching US$ 4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.6% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.92 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 4.60% 2030 Value Projection: US$ 4 Bn
Figure 1. Global Wilms Tumor Protein Market Share (%), by Region, 2023
Wilms Tumor Protein Market - IMG1

Wilms tumor protein is a transcription factor that plays an important role in the progression of various types of cancer. It has also been shown to be associated with resistance to chemotherapies. As a result, Wilms tumor protein has been proposed to be a promising target for the development of new anti-cancer drugs. According to NCBI, Wilms tumor protein is involved in the chromatin remodeling complex and promotes the expression of several genes. It has been shown to interact with several chemotherapeutic agents including daunorubicin and mitoxantrone.

Market Dynamics:

Increasing cancer cases worldwide is expected to drive growth of the global wilms tumor protein market over the forecast period. Moreover, increasing awareness regarding Wilms tumor and its treatment and diagnosis is also expected to propel growth of the global Wilms tumor protein market over the forecast period. According to the data published by American Cancer Society in January 2020, Wilms tumor stands as the predominant form of kidney cancer found in children. Annually, in the U.S., 500 to 600 new Wilms tumor cases are reported, a figure that has exhibited relatively consistent levels over an extended period. Wilms tumors account for approximately 5% of all childhood cancer cases.

However, high cost of diagnosis and treatment procedures is expected to hinder growth of the global Wilms tumor protein market over the forecast period. The high cost of diagnosis and treatment procedures can significantly hinder the growth of the global Wilms tumor protein market. Expensive diagnostic tests and treatments may limit accessibility for patients, particularly in regions with limited healthcare resources. This cost barrier could reduce patient uptake of Wilms tumor protein-related therapies and diagnostics, potentially impacting the market's expansion and inhibiting the ability to reach a broader patient population.

Key features of the study:

  • This report provides in-depth analysis of the global wilms tumor protein market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global wilms tumor protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abcam plc, Thermo Fisher Scientific, Inc., Santa Cruz Biotechnology, Inc., Novus Biologicals, LLC, R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation), OriGene Technologies, Inc., Cell Signaling Technology, Inc., Merck KGaA, BioLegend, Inc., Genetex, Inc. (a subsidiary of Novus Biologicals, LLC), Agilent Technologies, Inc., Proteintech Group, Inc., Sino Biological Inc., Boster Biological Technology, and Fitzgerald Industries International
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global wilms tumor protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wilms tumor protein market

Global Wilms Tumor Protein Market Detailed Segmentation:

  • By Product Type:
    • Antibodies
    • Assay Kits
    • Recombinant Proteins
    • Others
  • By Application:
    • Cancer Diagnosis
    • Cancer Treatment
    • Research and Development
    • Others
  • By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Research Institutes
    • Others
  • By Detection Method:
    • Immunohistochemistry (IHC)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Western Blotting
    • Polymerase Chain Reaction (PCR)
    • Others
  • By Disease Stage:
    • Diagnosis
    • Monitoring and Prognosis
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abcam plc
    • Thermo Fisher Scientific, Inc.
    • Santa Cruz Biotechnology, Inc.
    • Novus Biologicals, LLC
    • R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
    • OriGene Technologies, Inc.
    • Cell Signaling Technology, Inc.
    • Merck KGaA
    • BioLegend, Inc.
    • Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
    • Agilent Technologies, Inc.
    • Proteintech Group, Inc.
    • Sino Biological Inc.
    • Boster Biological Technology
    • Fitzgerald Industries International

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Wilms Tumor Protein, By Product Type
    • Market Wilms Tumor Protein, By Application
    • Market Wilms Tumor Protein, By End User
    • Market Wilms Tumor Protein, By Detection Method
    • Market Wilms Tumor Protein, By Disease Stage
    • Market Wilms Tumor Protein, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for targeted therapies for Wilms tumor treatment
  • Technological developments in the field of cancer diagnostics and treatment
    • Restraints
  • High cost of diagnosis and treatment procedures
    • Opportunities
  • Growing funding for research on Wilms tumor
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Wilms Tumor Protein Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Wilms Tumor Protein Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Assay Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Recombinant Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Wilms Tumor Protein Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Cancer Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cancer Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Wilms Tumor Protein Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Wilms Tumor Protein Market, By Detection Method, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Immunohistochemistry (IHC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Bn)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Western Blotting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Wilms Tumor Protein Market, By Disease Stage, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Monitoring and Prognosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

10. Global Wilms Tumor Protein Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2023-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Abcam plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Novus Biologicals, LLC
  • R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
  • OriGene Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KGaA
  • BioLegend, Inc.
  • Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
  • Agilent Technologies, Inc.
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Boster Biological Technology
  • Fitzgerald Industries International
  • Analyst Views

12. Section

  • Research Methodology
  • About us